Prostate
Conditions
Brief summary
This pilot clinical trial studies how well electronic patient reported outcomes work in measuring health-related quality of life in patients with stage I-IV prostate cancer undergoing treatment. Using a smartphone application to measure and monitor symptoms before, during, and after treatment may help patients better detect, understand, and manage their health.
Detailed description
PRIMARY OBJECTIVES: I. To explore the feasibility of collecting electronic patient-reported outcome data using validated health-related quality of life (HRQOL) assessment tools at baseline, during, and after treatment through a smartphone application in adult men throughout their course of treatment for prostate cancer.
Interventions
OTHERInternet-Based Intervention
Complete questionnaire via a smartphone application
Sponsors
Sidney Kimmel Cancer Center at Thomas Jefferson University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Self-reported ability to speak and read English * Be able to communicate on a touch screen iPhone * Willing to provide signed informed consent * Willing and able to comply with all study activities * Access to WiFi connection or cellular data * An established clinical history of prostate cancer in a spectrum of severity (all stages)
Exclusion criteria
* A subject will not be eligible for inclusion in this study if in the investigator's opinion the patient has any concurrent medical or psychiatric condition that may preclude participation in this study or completion of self-administered questionnaires (e.g., moderate to severe dementia and/or severe, uncontrolled schizophrenia, or other condition that would render them unable to complete a questionnaire) * Cognitive or other impairment (e.g., visual) that would interfere with completing a self- administered questionnaire and with participating in a group discussion
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility defined as satisfactory completion (60%) of weekly questionnaires | Up to 3 months | The rate of satisfactory completion will be estimated along with a one-sided exact 95% confidence interval. The method will be considered feasible if the lower bound of the confidence interval is above 0.7 or, equivalently, if at least 49/60 (82%) of participants have satisfactory completion. Rates of completion may be estimated by levels of baseline demographic or clinical characteristics. |
Countries
United States
Outcome results
None listed